Divis Laboratories Share Price Today | Stock Price & Divis Laboratories Share Screener

Track the current stock price of Divis Laboratories with an interactive chart. Analyse DIVISLAB share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Divis Laboratories stock quote in one place.

The quote of ₹9,190.00 sits between the 52-week low of ₹5,821.00 and the 52-week high of ₹9,624.00, and the latest session moved 1.13% from the previous close.

Screen Divis Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DIVISLAB shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, with Ramesh B V Nimmagadda listed as chairperson or CEO, and it trades under ISIN INE361B01024.

Divi's Laboratories Ltd is a leading pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs), Intermediates, and Nutraceuticals. The company operates globally with a presence in over 100 countries and has six manufacturing facilities. It offers both generic and custom synthesis services for pharmaceutical companies, supporting product development...more

Classification

Identifiers and Leadership

Screen DIVISLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹20,033, up from ₹16,932 in 2025.

Latest statistics put total assets at ₹20,033 and shareholder funds at ₹16,761.

Screen Divis Laboratories income statement and profit fundamentals. Analyze DIVISLAB quarterly results. Divis Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹3,144 and net profit was ₹902, equal to earnings per unit of ₹33.95, at an operating margin of 41%.

In that period expenses were ₹1,825, interest cost ₹6 and tax ₹278. The next period listed, 2026-Mar, shows revenue of ₹2,986 and net profit of ₹751.

Screen DIVISLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹2,738, and net cash flow was an outflow of ₹285.

Over the same period, investing activities used ₹2,219 and financing activities used ₹804.

See Divis Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Divis Laboratories promoter holding and ownership changes for DIVISLAB on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 51.88%, foreign institutions 20.29%, domestic institutions 19.22% and the public 6.48%, spread across 228,006 shareholders.

The shareholder count was 228,006 in 2026-Mar, compared with 226,324 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Divis Laboratories. Divis Laboratories dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹30.00 per unit for 2026-March, a yield of 0.33%, compared with ₹30.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹30.00, ₹30.00 and ₹30.00 per unit.

See which indices include Divis Laboratories stock. Check DIVISLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 39 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE 200 EQUAL WEIGHT, BSE INDEX BSE HC, BSE INDEX BSE100.

Get Divis Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Divis Laboratories stock events that may affect DIVISLAB share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated August 10, 2026, with a record date of August 10, 2026.

It is followed by Quarterly Result Announcement dated August 1, 2026 and Dividend dated July 24, 2026.

Screen DIVISLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen DIVISLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 6, 2026.

The next most recent announcements are dated September 30, 2026 and September 12, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 22, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.